In addition, recent studies have identified PP2A as a negative regulator of CD8+ T-cell effector functions in GBM, in which it suppresses T-cell receptor (TCR) signaling by dephosphorylating key activation nodes [250]. This evidence concerns the gene PTPA and glioblastoma.